Log in
Enquire now
‌

US Patent 10004786 Acylated glucagon analogues

Patent 10004786 was granted and assigned to Zealand Pharma A/S on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Zealand Pharma A/S
Zealand Pharma A/S
Current Assignee
Zealand Pharma A/S
Zealand Pharma A/S
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10004786
Date of Patent
June 26, 2018
Patent Application Number
14843047
Date Filed
September 2, 2015
Patent Citations Received
‌
US Patent 11034747 Glucagon analogues and methods of use
‌
US Patent 11008375 GIP-GLP-1 dual agonist compounds and methods
‌
US Patent 11884713 Acylated glucagon analogues
0
‌
US Patent 11274136 Acylated glucagon analogue
‌
US Patent 10336802 Acylated glucagon analogue
‌
US Patent 10457714 Acylated glucagon analogues
‌
US Patent 11001619 GIP agonist compounds and methods
Patent Primary Examiner
‌
Thomas S Heard
Patent abstract

The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes and associated metabolic disorders. In particular, the invention provides novel acylated glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10004786 Acylated glucagon analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us